| Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture MV Apte, PS Haber, TL Applegate, ID Norton, GW McCaughan, ... Gut 43 (1), 128-133, 1998 | 1110 | 1998 |
| Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study G Addolorato, L Leggio, A Ferrulli, S Cardone, L Vonghia, A Mirijello, ... The Lancet 370 (9603), 1915-1922, 2007 | 779 | 2007 |
| Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis MV Apte, PS Haber, SJ Darby, SC Rodgers, GW McCaughan, MA Korsten, ... Gut 44 (4), 534-541, 1999 | 688 | 1999 |
| Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis PS Haber, GW Keogh, MV Apte, CS Moran, NL Stewart, DHG Crawford, ... The American journal of pathology 155 (4), 1087-1095, 1999 | 524 | 1999 |
| Expression of the gene for multidrug-resistance–associated protein and outcome in patients with neuroblastoma MD Norris, SB Bordow, GM Marshall, PS Haber, SL Cohn, M Haber New England Journal of Medicine 334 (4), 231-238, 1996 | 408 | 1996 |
| Alcohol use disorders JP Connor, PS Haber, WD Hall The Lancet 387 (10022), 988-998, 2016 | 398 | 2016 |
| Traditional markers of excessive alcohol use KM Conigrave, P Davies, P Haber, JB Whitfield Addiction 98, 31-43, 2003 | 367 | 2003 |
| Prevalence and correlates of DSM‐IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing M Teesson, W Hall, T Slade, K Mills, R Grove, L Mewton, A Baillie, ... Addiction 105 (12), 2085-2094, 2010 | 258 | 2010 |
| Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic A Dunlop, B Lokuge, D Masters, M Sequeira, P Saul, G Dunlop, J Ryan, ... Harm reduction journal 17 (1), 1-7, 2020 | 256 | 2020 |
| An overview of the patterns of prescription opioid use, costs and related harms in a ustralia B Blanch, SA Pearson, PS Haber British journal of clinical pharmacology 78 (5), 1159-1166, 2014 | 235 | 2014 |
| Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi‐centre, randomized, double‐blind, placebo‐controlled trial KC Morley, M Teesson, SC Reid, C Sannibale, C Thomson, N Phung, ... Addiction 101 (10), 1451-1462, 2006 | 191 | 2006 |
| Guidelines for the treatment of alcohol problems. P Haber, N Lintzeris, E Proude, O Lopatko Commonwealth of Australia, 2009 | 185 | 2009 |
| Pathogenesis of alcohol‐induced liver disease: Classical concepts and recent advances D Seth, PS Haber, WK Syn, AM Diehl, CP Day Journal of gastroenterology and hepatology 26 (7), 1089-1105, 2011 | 183 | 2011 |
| Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort JJ Post, Y Pan, AJ Freeman, CE Harvey, PA White, P Palladinetti, ... Journal of Infectious Diseases 189 (10), 1846-1855, 2004 | 180 | 2004 |
| Effective treatment of injecting drug users with recently acquired hepatitis C virus infection GJ Dore, M Hellard, GV Matthews, J Grebely, PS Haber, K Petoumenos, ... Gastroenterology 138 (1), 123-135. e2, 2010 | 173 | 2010 |
| Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. SB Bordow, MD Norris, PS Haber, GM Marshall, M Haber Journal of clinical oncology 16 (10), 3286-3294, 1998 | 172 | 1998 |
| Fatty acid ethyl esters increase rat pancreatic lysosomal fragility PS Haber, JS Wilson, MV Apte, RC Pirola The Journal of laboratory and clinical medicine 121 (6), 759-764, 1993 | 165 | 1993 |
| Examination of opioid prescribing in Australia from 1992 to 2007 M Leong, B Murnion, PS Haber Internal medicine journal 39 (10), 676-681, 2009 | 164 | 2009 |
| Alcoholic liver disease in asia, europe, and north America S Liangpunsakul, P Haber, GW McCaughan Gastroenterology 150 (8), 1786-1797, 2016 | 162 | 2016 |
| Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition TR Arkell, N Lintzeris, RC Kevin, JG Ramaekers, R Vandrey, C Irwin, ... Psychopharmacology 236, 2713-2724, 2019 | 147 | 2019 |
Maree TeessonUniversity of Sydney在 sydney.edu.au 的电子邮件经过验证
